Home

Francès C, Cosnes A, Duhaut P, Zahr N, Soutou B, Ingen-Housz-Oro S, Bessis D, Chevrant-Breton J, Cordel N, Lipsker D, Costedoat-Chalumeau N; Archives of Dermatology 148 (4), 479-84 (Apr 2012)

Source: Arch Dermatol

Tags:

hydroxychloroquine

Lupus

Treatment of Systemic Sclerosis Complications: What to Use When First-Line Treatment Fails-A Consensus of Systemic Sclerosis Experts

Walker KM, Pope J, participating members of the Scleroderma Clinical Trials Consortium (SCTC), Canadian Scleroderma Research Group (CSRG); Seminars in Arthritis and Rheumatism (Mar 2012)

Source: Semin Arthritis Rheum

Tags:

Arthritis

azathioprine

cyclophosphamide

Esophagitis/GERD

hydroxychloroquine

Interstitial Lung Disease

methotrexate

mycophenolate mofetil

mycophenolic acid

Pulmonary Hypertension

Page 21 of 48

I-ADD Study: Assessment of Efficacy and Safety Profile of Irbesartan/Amlodipine Fixed-Dose Combination Therapy Compared With Irbesartan Monotherapy in Hypertensive Patients Uncontrolled With Irbesartan 150 mg Monotherapy: A Multicenter, Phase III, Prospec

Abatacept for lupus nephritis: Alternative definitions of complete response support conflicting conclusions

Low blood concentration of hydroxychloroquine in patients with refractory cutaneous lupus erythematosus: a French multicenter prospective study

Treatment of Systemic Sclerosis Complications: What to Use When First-Line Treatment Fails-A Consensus of Systemic Sclerosis Experts

Main Menu

Statistics

Most Read Content